K 023260 oO
_
SMDA_ 510(k) Summary of Safety and Effectiveness
This summary of safety and effectiveness information is being submitted in accordance with the
requirements of SMDA 1990 and 21 CFR Part 807 subpart E, Section 807.92.
A. Sponsor /Manufacturer Name and Address
1. Applicant
Olympus Optical Co., Ltd.
2-3-1 Shinjuku Monolis Nishi-shinjuku DEC 1 9 2002
Shinjuku-ku, Tokyo, Japan, 163-0914
Establishment registration number : 8010047
2. Initial Importer
Olympus America Inc.
Two Corporate Center Drive
Melville, NY 11747-3157
Establishment registration number : 2429304
3. Contact Person
Laura Storms-Tyler
Director, Regulatory Affairs
Olympus America Inc.
Two Corporate Center Drive
Melville, NY 11747-3157 /
Tel 631-844-5688
Fax 631-844-5416
B. Device Name, Common Name
1. Common/Usual Name
Electrosurgical Unit and its ancillary equipment.
2. Device Name .
Olympus PSD-20 Electrosurgical System and its associated accessories
3. Classification
21 CFR 876.4300 Endoscopic electrosurgical unit and accessories,
Class I
C. Identification of the predicate or legally marketed device
The following devices are substantially equivalent device in consideration to its
characteristics or specification.
Olympus PSD-20 Electrosurgical K970797 Olympus Optical Co., Ltd.
Unit and its associated accessories
(For GI application )
Olympus UES-20 Electrosurgical Units K970184 Olympus Optical Co., Ltd.
and its associated accessories
(For urology application)
D. Device Description
1

LO2 32% © @)
Ta Ss
1. Summary
This instrument has been designed to be used with Olympus recommended Electrosurgical
accessories, Endoscope, Light Source and other ancillary equipment for flexible cystoscopic
treatment (cutting and coagulating)
Recommended endoscopes for this instrument are Olympus’s series CYF series, and
Olympus's electrosurgical instruments such as electrosurgical snare, hot biopsy forceps.
Other Olympus electrosurgical devices or instruments can be used with this subject device.
Be sure to check compatibility for each device in each instruments instruction manual.
The PSD-20 unit offers Monopolar, output modes; 5 Cut modes (PURE, BLEND 1/2/3/4),
4 Coagulation mode, (NORMAL COAGULATION), It offers several features to ensure the
safe operation of the unit. For example, the voltage output level setting and a monitor circuit
detect irregularity or improper connections.
2. Design
This device has been designed to be complying with the following voluntary standards.
*1EC 60601-1
“(EC 60601-2-2
-lIEC 60601-2-18
*1EC 60601-1-2 (EMC)
3. Materials
There aren't any patient contacting material in PSD-20 itself. Some ancillary equipment
have patient contact materials, however there are no new patient contacting material in
those devices.
4. Technology
This device does not have any special technology or characteristic i.e. this device is intended to
provide electrical power to accessories (such as biopsy) via the use of high frequency electrical
current waveform passing into the tissue during endoscopic urological treatment.
E. Indication for Use
This instrument has been designed to be used with Olympus recommended Electrosurgical
accessories, Endoscope, Light Source and other ancillary equipment for flexible cystoscopic
treatment (cutting and coagulating) including:
- Hemostasis of superficial bleeding
- Treatment of bladder tumors
- Treatment of stenosis inside urinary tract.
2

enmmetny oo
e J _ _ DEPARTMENT OF HEALTH & HUMAN SERVICES _ Public Health Service .
“ : / : - Food and Drug Administration
: : oO . : : 9200 Corporate Boulevard
. . , | - : Rockville MD 20850 .
: Olympus Optical Company, LTD. . , " ——
. Laura Storms-Tyler . nen 4 Qe
Director, Regulatory Affairs oo bec 19 2002
, Olympus AmericaInc. ~  ” .
. Two Corporate Center Drive | . oo
Melville, New York 11747-3157 ‘ : .
Re: K023280
Trade/Device Name: Olympus PSD-20 Electrosurgical System
Regulation Number: 878.4400
Regulation Name: Endoscopic electrosurgical unit and accessories
Regulatory Class: Class II
Product Code: GE]
Dated: September 30. 2002
Received: October 1. 2002
Dear Ms. Storms-Tyler:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications for
use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce
prior to May 28, 1976. the enactment date of the Medical Device Amendments, or to devices that
have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic
Act (Act) that do not require approval of a premarket approval application (PMA). You may.
therefore, market the device, subject to the general controls provisions of the Act. The general
controls provisions of the Act include requirements for annual registration, listing of devices, good
manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class I] (Special Controls) or class II] (PMA). it
may be subject to such additional controls. Existing major regulations affecting your device can
‘ be found in the Code of Federal Regulations. ‘litle 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Rewister.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must comply
with all the Act's requirements, including, but not limited to: registration and listing (21 CFR
Part 807); labeling (21 CFR Part 801); good manutacturing practice requirements as set forth in

- Page 2—Ms. Laura Storms-Tyler — - . coe o
a '. the quality systems (QS) regulation (21 CER Part 820); and if applicable, the electronic product ~ radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.° .
. : This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
, .. marketed predicate device results in a classification for your device and thus, permits your device _
: . ‘to proceed to the market. , Lo mo, .
‘Ifyou desire specific advice for your device on-our labeling regulation (21 CFR Part-801), please
. contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion
: and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also,
please note the regulation entitled, “Misbranding by reference to premarket notification” (21CFR
Part 807.97). Other general information on your responsibilities under the Act may be obtained
from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free
number (800) 638-2041 or (301) 443-6597 or at its Internet address
htto: //www.fda.gqov/cdrh/dsma/dsmamain. html
Sincerely yours,
ss } f
Mean C Vrevertfe¥ Celia M. Witten, Ph.D., MD
Director
Division of General, Restorative
and Neurological Devices
Office of Device Evaluation
Center for Devices and
Radiological Health
Enclosure

: _~ §10(k) Number(if known): kK © a 3 2 6 . oo , eo
: Device Name:_ Olympus PSD-20 Electrosurgical System and its associated accessories ~ ,
Indications for Use: : .
: This ‘instrument has been designed to be used with Olympus recommended
Electrosurgical accessories, Endoscope, Light Source and other ancillary equipment for
flexible cystoscopic treatment (cutting and coagulating) including:
- Hemostasis of superficial bleeding
- Treatment of bladder tumors : ao
- Treatment of stenosis inside urinary tract.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use_ OR Over-The-Counter Use
(Per 21 CFR 801.109)
: (Optional Format 1-2-96)
aualrabe ae .
vision of Gras. 4) ‘testorauve
K 623260

